ANDA 71064, held by Fosun Pharma. Amitriptyline Hydrochloride; Perphenazine.
As of Nov 15, 2026, ANDA 71064 (Perphenazine And Amitriptyline Hydrochloride), held by Fosun Pharma, was first approved by FDA on Nov 27, 1987, with 17 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 27, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Perphenazine And Amitriptyline Hydrochloride25MG;4MG · tablet;oral | Amitriptyline Hydrochloride; Perphenazine | Discontinued |
| Jun 24, 2025 | Supplement 22Labeling · Standard review | Approved | None posted |
| Jan 22, 2025 | Supplement 21Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 20Labeling · Standard review | Approved | None posted |
| Apr 25, 2016 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jan 17, 2015 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jul 18, 2014 | Supplement 17Labeling · Standard review | Approved | None posted |
| Dec 6, 2012 | Supplement 16Labeling | Approved | None posted |
| Aug 8, 2001 | Supplement 11Manufacturing | Approved | None posted |
| Apr 2, 2001 | Supplement 10Manufacturing | Approved | None posted |
| May 5, 1999 | Supplement 9Manufacturing | Approved | None posted |
| Oct 28, 1997 | Supplement 8Manufacturing | Approved | None posted |
| May 14, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Apr 26, 1996 | Supplement 6Manufacturing | Approved | None posted |
| Apr 10, 1995 | Supplement 5Labeling | Approved | None posted |
| Jan 24, 1994 | Supplement 4Manufacturing | Approved | None posted |
| Jun 29, 1993 | Supplement 3Labeling | Approved | None posted |
| Sep 9, 1988 | Supplement 2Labeling | Approved | None posted |
| Nov 27, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters